Circulating androgen receptor gene amplification and resistance to 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: results of a Phase 2 trial.
Ugo De GiorgiMaddalena SansoviniStefano SeveriSilvia NicoliniManuela MontiGiorgia GurioliFlavia FocaChiara CasadeiVincenza ConteducaMonica CelliValentina Di IorioDaniele CalistriFederica MatteucciFinn Edler von EybenGerhardt AttardGiovanni PaganelliPublished in: British journal of cancer (2021)
NCT03454750.